Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies

27 Oct 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomic variations and chromosomal abnormalities
Share to Genomics and Rare Diseases
Share to Neurogenetic and Muscular Disorders Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33110268
DOI: 10.1038/s41436-020-01012-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomaliesPMID 33110268Read ↗

Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum DisorderSemantic proximity Read ↗

Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from CanadaSemantic proximity Read ↗

Systematic evaluation of genome sequencing for the diagnostic assessment of autism spectrum disorder and fetal structural anomaliesSemantic proximity Read ↗

Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disabilitySemantic proximity Read ↗

Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual DisabilitySemantic proximity Read ↗

Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysisSemantic proximity Read ↗

Advancing access to genome sequencing for rare genetic disorders: recent progress and call to actionSemantic proximity Read ↗

Genomic sequencing for the diagnosis of childhood mitochondrial disorders: a health economic evaluationSemantic proximity Read ↗

Return of whole-genome sequencing results in paediatric research: a statement of the P3G international paediatrics platformSemantic proximity Read ↗

Report – Cost and Clinical Utility of WES and WGS in pediatric patients with suspected genetic diseaseSemantic proximity Read ↗

A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of careSemantic proximity Read ↗

A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.